Phase I trial of the anti-idiotypic monoclonal antibody (mAb) ACA-125 in patients with epithelial ovarian, fallopian tube or primary peritoneal cancer This is an ASCO Meeting Abstract from the 2004 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results